(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole

We are (R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole CAS:143322-57-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole
CAS.NO:143322-57-0
Synonyms:(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole
5-bromo-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole
5-Bromo-3-{[(2R)-1-methyl-2-pyrrolidinyl]methyl}-1H-indole
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 412.9±25.0 °C at 760 mmHg
Molecular Formula C14H17BrN2
Molecular Weight 293.202
Flash Point 203.5±23.2 °C
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.655
 
Specification:
Appearance:Off-white powder
Assay(HPLC):≥95.0%
Specific rotation:+75°~+80°
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Eletriptan(CAS:143322-58-1)、Eletriptan hydrobromide(CAS:177834-92-3) and Eletriptan hydrobromide monohydrate(CAS:273211-28-2).

(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole


Related News: Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.1187595-85-2 It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation.156-87-6 Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.ethyl (2Z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.

Related Products
Product Name
1-hydroxy-6-(trifluoromethyl)-1h-benzotriazole View Details
2,4,5-Trifluorobenzoic acid View Details
3-Methylbenzoic acid View Details
ethyl oleate manufacturer 3,5-Dioxocyclohexanecarboxylic Acid manufacturer N-Fmoc-N-methyl-D-alanine manufacturer 1-isothiocyanato-4-methoxybenzene manufacturer 1-Mercaptooctane manufacturer